B16 Cells
| Unit |
3 x 10^6 cells/ml |
|---|---|
| Cell Type |
Tumor Cells |
| Tissue Type |
Mouse cell lines |
| Organism |
Mouse |
| Donor History |
Mouse melanoma |
| Growth Properties |
Adherent |
| Growth Conditions |
Culture medium: EMEM (MEM Eagle) ,w: 2 mM L-Glutamine ,w: 2.2 g/L NaHCO3 ,w: EBSS (Cytion article number 820100a). Supplements: Supplement the medium with 10% FBS and 1% NEAA. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
The B16 cell line is a widely used murine model derived from melanoma tumors in C57BL/6 mice. This line is extensively employed in research due to its ability to form melanotic tumors that closely resemble human melanoma in terms of growth characteristics and metastatic potential. The cell line exists in various subtypes, such as B16-F0, B16-F1, and B16-F10, with each subtype demonstrating varying degrees of metastatic capability; for instance, B16-F10 is highly metastatic compared to B16-F0. These variations allow researchers to select an appropriate model based on the specific requirements of their studies concerning tumor aggressiveness and metastasis.
B16 cells are instrumental in understanding the molecular and cellular mechanisms of melanoma progression and testing anti-cancer therapies. Their melanin-producing ability makes them particularly useful for studies on melanogenesis and its regulation. Furthermore, the B16 cell line serves as an essential tool for vaccine development and immunotherapy experiments, offering insights into tumor-immune system interactions and the efficacy of immunomodulatory agents. The adaptability of these cells to various in vivo and in vitro environments underscores their significance in translational and preclinical research aimed at melanoma treatment and prevention.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

